Charles Drake
Physician · Columbia University Vagelos College of Physicians and Surgeons
Credentials: · · · ·
History
- 2000–2003
Hematology and Medical Oncology
- 1997–2000
Internal Medicine
Research
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
New England Journal of Medicine · 2012 · 10,404 citations
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
New England Journal of Medicine · 2012 · 6,533 citations
Immune checkpoint blockade: a common denominator approach to cancer therapy
Review · Cancer Cell · 2015 · 3,416 citations

34 papers

27 papers

19 papers · 1 as a fellow

18 papers · 9 as a resident

16 papers
- TB
16 papers · 9 as a resident

15 papers
- NH
13 papers
Grants
- 1997–2022
Regional Oncology Research Center
National Cancer Institute · P30
Project lead · $2.2M · Johns Hopkins University
- 2018–2019
NIH Office of the Director · S10
Contact PI · $600K · Columbia University Health Sciences
- 2012–2017
Role of Tc17 Cells in Tumor Immunotherapy
National Cancer Institute · R01
Contact PI · $1.3M · Johns Hopkins University
- 2008–2014
National Cancer Institute · P50
Project lead · $1.4M · Johns Hopkins University
Clinical trials
- 2008
Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer
Study chair · Withdrawn · Phase 2
Eastern Cooperative Oncology Group


